71. Martinez-Gonzalez M.A., de la Fuente-Arrillaga C., Nunez-Cordoba J.M. et al. Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study. BMJ. 2008 Jun 14; 336(7657):1348-51.
72. Ryan M.C., Itsiopoulos C., Thodis T. et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013 Jul;59(l):138-43. doi: 10.1016/j. jhep.2013.02.012. Epub 2013 Feb 26.
73. TuomilehtoJ., Lindström J., Eriksson J., et al., for the Finnish Diabetes Prevention Study Group. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. N Engl J Med 2001; 344:1343–1350. DOI: 10.1056/NEJM200105033441801.
74. Nadtochiy S.M., Redman E.K. Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids and polyphenols. Nutrition (Burbank, Los Angeles County, Calif). 2011;27(7–8):733–744. doi:10.1016/j.nut.2010.12.006.
75. Simopoulos A.P. Human requirement for Q-3 polyunsaturated fatty acids. Poult Sei. 2000 Jul; 79(7):961-70.
76. Weber P.C., Leaf A. Cardiovascular effects of omega-3 fatty acids. Atherosclerosis risk factor modification, 1991.
77. Rodriguez-Leyva D., et al. The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid. Can J Cardiol. 2010 November; 26(9): 489–496.
78. Leyva D.R., Zahradka P., Ramjiawan B., et al. The effect of dietary flaxseed on improving symptoms of cardiovascular disease in patients with peripheral artery disease: rationale and design of the FLAX-PAD randomized controlled trial. Contemp Clin Trials. 2011; 32: 724–730.
79. Parker H.M., Johnson N.A., Burdon C.A., et al. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012 Apr;56(4):944-51. doi: 10.1016/j.jhep.2011.08.018.
80. Sonne D.P., Knop F.K. Cardiovascular effects of alpha-linolenic acid-a possible role of glucagon-like peptide-1. Exp Biol Med (Maywood). 2013 Oct;238(10):1116-7. doi: 10.1177/1535370213503434.
81. Gundermann K.-J., Gundermann S., Drozdzik M., Mohan Prasad V. Essential phospholipids in fatty liver: a scientific update. Clinical and Experimental Gastroenterology. 2016;9:105–117. doi:10.2147/CEG.S96362.
82. Kidd P.M. Cell membranes, endothelia, and atherosclerosis — the importance of Phosphatidylcholine. Altern Med Rev 1996;1:148–167.
